Mineralys Therapeutics, Inc.

MLYS · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$114,091$49,304$87,701$10,612
Short-Term Investments$84,096$187,263$22,409$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$7,164$12,536$2,701$510
Total Curr. Assets$205,351$249,103$112,811$11,122
Property Plant & Equip (Net)$53$0$0$0
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$2,482$0$0
Tax Assets$0$0$0$0
Other NC Assets$499$51$1,631$3
Total NC Assets$552$2,533$1,631$3
Other Assets$0$0$0$0
Total Assets$205,903$251,636$114,442$11,125
Liabilities
Payables$479$601$1,907$763
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$14,167$9,881$6,160$4,291
Total Curr. Liab.$14,646$10,482$8,067$5,054
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$158,644$28,996
Total NC Liab.$0$0$158,644$28,996
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$14,646$10,482$166,711$34,050
Equity
Pref Stock$0$251,636$0$28,996
Common Stock$5$4$1$1
Retained Earnings-$302,518-$124,708-$52,810-$23,011
AOCI$0-$251,636$0$0
Other Equity$493,770$365,858$540-$28,911
Total Equity$191,257$241,154-$52,269-$22,925
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$205,903$251,636$114,442$11,125
Net Debt-$114,091-$49,304-$87,701-$10,612